Modulation by polyelectrolytes of canine cardiac microsomal calcium uptake and the possible relationship to phospholamban.
Calcium uptake and (Ca2+ + Mg2+)-ATPase activity in canine cardiac microsomes were found to be stimulated by heparin and various other polyanions. Prior treatment of the microsomes with the ionophores alamethicin or A23187 produced no change in the extent of stimulation of the ATPase activity by heparin yet eliminated net calcium uptake. This finding and a lack of change in the stoichiometric ratio of mol of calcium transported/mol of ATP hydrolyzed (calcium:ATP) suggest that the effect of heparin is on the calcium pump rather than on a parallel calcium efflux pathway. Certain polycationic compounds including poly-L-arginine and histone inhibited both cardiac and fast skeletal muscle microsomal calcium uptake and also produced no change in the stoichiometric ratio of calcium to ATP. Several lines of evidence indicate that the polyanionic compounds tested stimulate calcium uptake by interacting with phospholamban, the putative phosphorylatable regulator of the cardiac sarcoplasmic reticulum calcium pump, whereas polycationic compounds appear to interact with the pump. (i) Heparin stimulated calcium uptake to the same extent as protein kinase A or trypsin, whereas prior phosphorylation or tryptic cleavage of phospholamban from the membrane abolished the stimulatory effect of heparin. (ii) Calcium uptake and (Ca2+ + Mg2+)-ATPase activity in fast skeletal muscle microsomes, which lack phospholamban, were unaffected by heparin. (iii) Purified cardiac (Ca2+ + Mg2+)-ATPase activity was no longer stimulated by heparin yet was still inhibited by polycationic compounds. The heparin-induced stimulation of calcium uptake was dependent on the pH and ionic strength of the heparin-containing preincubation medium, hence electrostatic interactions appear to play a significant role in heparin's stimulatory action. The data are consistent with an inhibitory role of the positively charged cytoplasmic domain of phospholamban with respect to calcium pump activity and the relief of the inhibition upon reduction in phospholamban's positive charge by phosphorylation or binding of polyanions.
Xu
Z C
ZC
Department of Physiology and Biophysics, Mount Sinai School of Medicine, City University of New York, New York 10029.
Kirchberger
M A
MA
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000408:Alamethicin / Q000494:pharmacology; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase / Q000378:metabolism*; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D002135:Calcium-Binding Proteins / Q000378:metabolism*; D000252:Calcium-Transporting ATPases / Q000378:metabolism*; D016264:Dextran Sulfate; D003911:Dextrans / Q000494:pharmacology; D004285:Dogs; D006493:Heparin / Q000494:pharmacology*; D006657:Histones / Q000494:pharmacology; D007700:Kinetics; D008861:Microsomes / Q000187:drug effects / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D010455:Peptides / Q000494:pharmacology*; D010774:Phosvitin / Q000494:pharmacology; D011073:Polyamines / Q000494:pharmacology; D012519:Sarcoplasmic Reticulum / Q000378:metabolism; D000099211:Phospholamban
D000251:Adenosine Triphosphatases; D000408:Alamethicin; D017301:Ca(2+) Mg(2+)-ATPase; D000001:Calcimycin; D002118:Calcium; D002135:Calcium-Binding Proteins; D000252:Calcium-Transporting ATPases; D016264:Dextran Sulfate; D003911:Dextrans; D006493:Heparin; D006657:Histones; D010455:Peptides; D010774:Phosvitin; D011073:Polyamines; D000099211:Phospholamban